Shawn Singh - Dec 31, 2021 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
Dec 31, 2021
Transactions value $
$6,005
Form type
4
Date filed
1/3/2022, 03:17 PM
Previous filing
Jul 2, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $6.01K +3.62K +7.98% $1.66 49K Dec 31, 2021 Direct F1
holding VTGN Common Stock 26.2K Dec 31, 2021 By The 1997 Singh Family Trust U/R/D 05/29/97
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)